Disc Medicine Inc. (IRON) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $67.91
• Market Cap: $2.53B
• EPS: $-5.37
• 52-Week High: $99.50
• 52-Week Low: $30.82

Market Sentiment

Disc Medicine Inc. currently has a Neutral sentiment score of 0.09.

About Disc Medicine Inc.

Disc Medicine Inc. (IRON) is a clinical-stage biotechnology company headquartered in Watertown, Massachusetts, dedicated to the advancement of innovative therapies for patients with serious hematologic diseases. The company boasts a comprehensive pipeline designed to target significant unmet medical needs in hematology, utilizing state-of-the-art drug development methodologies and thorough scientific research. Disc Medicine is strategically positioned to reshape the treatment paradigm for hem...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Disc Medicine Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does IRON pay dividends?

Disc Medicine Inc. (IRON) does not currently pay a regular dividend.

What is IRON's market cap?

Disc Medicine Inc. (IRON) has a market capitalization of $2.53B with a current stock price of $67.91.